Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference4%

- Check28 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check43 days agoChange Detected- Updated core content: Revision updated from v3.0.1 to v3.0.2. - Minor UI change: 'Back to Top' removed.SummaryDifference0.3%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page has undergone significant updates, including the addition of a facility name and location in Paris, France, as well as the introduction of new medical terms related to myelodysplastic syndrome and various compounds. Notably, azacitidine and durvalumab have been removed from the page.SummaryDifference5%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.